PMA device
Healon, Healon Gv & HEALON5 Sodium Hyaluronate Ophthalmic Viscoelastic Devices
Johnson & Johnson Surgical Vision, Inc. · Aid, Surgical, Viscoelastic (LZP, Class III) · First FDA decision Aug 16, 2007, newest Aug 1, 2008Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
2
Naming "Healon Healon Gv"
MAUDE reports
0
Brand "Healon Healon Gv", since 2015
PubMed studies
0
Mentioning "Healon Healon Gv"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Healon, Healon Gv & HEALON5 Sodium Hyaluronate Ophthalmic Viscoelastic Devices
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
P810031-S035 · Decided Aug 1, 2008 · 196 days after receipt · Normal 180 Day Track No User Fee
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
P810031-S031 · Decided Aug 16, 2007 · 321 days after receipt · Normal 180 Day Track No User Fee
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Healon Healon Gv", any status and sponsor, newest update first.
Bohus Biotech ABNot on our public-company list
NCT07184437 · 134 participants · Start Feb 20, 2024 · Primary completion Jun 19, 2025
Device: OVD-F device Minivisc®PLUS 14 mg/ml · For: Cataract
Sites: Leuven, Belgium; Falun, Sweden; Stockholm, Sweden · 6 sites in all
Nova Eye, Inc.Not on our public-company list
NCT04769453 · 20 participants · Start Apr 29, 2021 · Primary completion Jan 26, 2023
Device: Canaloplasty using the iTrack microcatheter with Healon GV Pro; Canaloplasty using the Omni surgical system with Healon GV Pro and 2 more · For: Primary Open Angle Glaucoma
Sites: Glendale, Arizona; Beverly Hills, California; Orange, California · 7 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Healon Healon Gv", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LZP
1,607 reports: 550 malfunction, 1,056 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision Inc
Z-0867-2020 · Started Dec 3, 2019 · Posted by FDA Jan 27, 2020
Reason given: Ophthalmic viscosurgical device may be difficult to remove from the eye, leading to increased postoperative intraocular pressure requiring additional intervention. Also, reports of clogging of phacoemulsion equipment tubing, which may lead to delay in the procedure or ocular injury.
Cause as FDA categorized it: Labeling False and Misleading · Device type: Aid, Surgical, Viscoelastic (LZP)
Abbott Medical Optics Inc. (AMO)
Z-2062-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design · Device type: Aid, Surgical, Viscoelastic (LZP)
Abbott Medical Optics Inc. (AMO)
Z-2063-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design · Device type: Aid, Surgical, Viscoelastic (LZP)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Healon Healon Gv"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LZP.
- PROVISC Ophthalmic Viscosurgical DeviceAlcon Research, Ltd. · PMA 2026
- Sodium Hyaluronate Ophthalmic Viscoelastic Devices (OVD)Johnson & Johnson Surgical Vision, Inc. · PMA 2024
- Amvisc & Amvisc Plus OvdBausch & Lomb, Inc. · PMA 2017
- Staarvisc II & Shellgel Sodium HyauronateAnika Therapeutics, Inc. · PMA 2012
- VISCOAT Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2026
- DISCOVISC Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2021
- Cellugel(R) Ophthalmic Viscosurgical DeviceAlcon Laboratories · PMA 2016
- Ocucoat (2% Hydroxpropylmethylcellulose Solution)Bausch & Lomb, Inc. · PMA 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.